Peter Kim compensation

[Anonymous]

What an AMAZING POST!!! Best I've ever seen on CP. I can't believe this is PUBLIC.

When you know what to look for, you'd be amazed at what confidential information is just hanging out in public. His salary is really no big deal, most of the details go into the SEC filings because he's paid so well now.

 

[Anonymous]

When you know what to look for, you'd be amazed at what confidential information is just hanging out in public. His salary is really no big deal, most of the details go into the SEC filings because he's paid so well now.

I wish I could get paid well as this guy and not be held accountable for my productivity.

MERCK & CO. INC.
(MRK:New York)
LAST $31.71 USDCHANGE TODAY +0.20 0.63%VOLUME 30.5MMRK On Other ExchangesAs of 8:04 PM 08/5/11 All times are local (Market data is delayed by at least 15 minutes).
SnapshotNewsChartsFinancialsEarningsPeopleOwnershipTransactionsOptions
OverviewBoard MembersCommittees EXECUTIVE PROFILE*
Peter S. Kim Ph.D.
Executive Vice President and President of Merck Research Laboratories, Merck & Co. Inc.
00
Age Total Calculated Compensation This person is connected to 0 board members in 0 different organizations across 4 different industries.


52 $6,518,625
As of Fiscal Year 2010
BACKGROUND*
Peter S. Kim PhD has been the President of Merck Research Laboratories at Merck & Co. Inc. and Merck Frosst Canada Ltd. since January 2003. Dr. Kim has been an Executive Vice President of Merck & Co. Inc. since January 2008. He is a Scientific Co-Founder of Osel Inc. He served as an Executive Vice President of Research and Development at MRL from 2001 to 2002. He served as an Associate Head of Department of Biology at MIT from 1999 to 2001, Investigator of Howard Hughes ... Medical Institute from 1997 to 2001, Professor of Biology at M.I.T., from 1995 to 2001, Associate Professor of Biology at M.I.T., from 1992 to 1995, Assistant Investigator at Howard Hughes Medical Institute from 1990 to 1993, Assistant Professor of Biology at M.I.T., from 1988 to 1992 and Whitehead Fellow, Whitehead Institute for Biomedical Research from 1985 to 1988. Dr. Kim has been a Member of Board of Directors of Fox Chase Cancer Center since 2003 and Whitehead Institute for Biomedical Research since 2005. He served as a Member of Oversight Committee, Division on Earth and Life Studies, The National Academies from 2006 to 2008 and also as a Member of Council, Institute of Medicine, National Academy of Sciences, from 2006 to 2008. He has been a Member of National Academy of Sciences since 1997, Fellow of American Academy of Microbiology since 1997, Fellow of American Association for the Advancement of Science since 1999, Member of Korean Academy of Science and Technology since 1999, Fellow of Biophysical Society since 1999 and a Member of Institute of Medicine, National Academy of Sciences since 2000. He served as a Member of Whitehead Institute for Biomedical Research from 1992 to 2001. Dr. Kim received National Academy of Sciences Award in Molecular Biology in 1993, Eli Lilly Award in Biological Chemistry in 1994, Dupont Merck Young Investigator Award in 1994, Pfizer Animal Health Award in 1995, Ho-Am Prize for Basic Science, Samsung Foundation in 1998, Hans Neurath Award, Protein Society in 1999 and Harvey Lecture, The Harvey Society in 2002. He was a member of The Whitehead Institute Dr. Kim holds Ph.D., in Biochemistry from Stanford University in 1985 and A.B. in Chemistry from Cornell University in 1979.

Read Full Background

CORPORATE HEADQUARTERS*
One Merck Drive
Whitehouse Station, New Jersey 08889-0100

United States

Phone: 908-423-1000
Fax: 908-298-7082
Board Members MEMBERSHIPS*
There is no Board Members Memberships data available.
EDUCATION*
PhD
Stanford University
BA 1979
Cornell University
OTHER AFFILIATIONS*
Stanford University
Cornell University
Merck Research Laboratories
Merck Frosst Canada Ltd.
Osel Inc. ANNUAL COMPENSATION*
Salary $1,093,524
Total Annual Compensation $1,093,524

STOCK OPTIONS*
Restricted Stock Awards $1,883,207
All Other Compensation $30,874
Exercisable Options 1,042,687
Exercisable Options Value $1,451,245
Unexercisable Options 367,806
Unexercisable Options Value $2,339,299
Total Value of Options $3,790,544
Total Number of Options 1,410,493

TOTAL COMPENSATION*
Total Annual Cash Compensation $2,358,103
Total Short Term Compensation $1,093,524
Other Long Term Compensation $1,914,081
Total Calculated Compensation $6,518,625


*Data is at least as current as the most recent Definitive Proxy.

 

[Anonymous]

What has he done to deserve this?

1. bought Sirna for 1b and only to find out it is useless
2. closed Merck Frosst, the most productive research site in the company
3. moved people around from site to site every year and make sure they wonder where they will be next year
4. laid off experienced scientists who know the most about drug discovery
5. hired/promoted a bunch of incompetent to lead Merck Research Labs
6. converted the research labs into an assembly line by implementing Six Sigma
7. lied to senior management and Wall Street about the pipeline
8. still had no clue about drug discovery after 10 years as MRL president
9. fooled two CEOs and thinking about how to do the same to the third
10. got overcompensated for doing nothing